Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis

References

• BloomDECafieroEJané-LlopisEThe global economic burden of noncommunicable diseasesWorld Econ Forum2011146
   Google Scholar
• PavlovaNNThompsonCBThe Emerging Hallmarks of Cancer MetabolismCell Metab201623274726771115
   PubMed Web of Science ®Google Scholar
• WeberCEKuoPCThe tumor microenvironmentSurg Oncol20122117217721963199
   PubMed Web of Science ®Google Scholar
• StrattonMRCampbellPJFutrealPAThe cancer genomeNature200945871972419360079
   PubMed Web of Science ®Google Scholar
• DavidsonNEArmstrongSACoussensLMAACR Cancer Progress Report 2016Clin Cancer Res20162219 supplS1S13727697776
   PubMed Web of Science ®Google Scholar
• EngebraatenOVollanHKMBørresen-DaleA-LTriple-negative breast cancer and the need for new therapeutic targetsAm J Pathol20131831064107423920327
   PubMed Web of Science ®Google Scholar
• BanerjiSCibulskisKRangel-EscarenoCSequence analysis of mutations and translocations across breast cancer subtypesNature201248640540922722202
   PubMed Web of Science ®Google Scholar
• AbramsonVGLehmannBDBallingerTJPietenpolJASubtyping of triple-negative breast cancer: implications for therapyCancer201512181625043972
   PubMed Web of Science ®Google Scholar
• PlasilovaMLHayseBKilleleaBKHorowitzNRChagparABLanninDRFeatures of triple-negative breast cancerMedicine (Baltimore)201695e461427583878
   PubMed Web of Science ®Google Scholar
• LuJLiongMLiZZinkJITamanoiFBiocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animalsSmall201061794180520623530
   PubMed Web of Science ®Google Scholar
• FilgueirasMDCMorrotASoaresPMGCostaMLMermelsteinCEffects of 5-fluorouracil in nuclear and cellular morphology, proliferation, cell cycle, apoptosis, cytoskeletal and caveolar distribution in primary cultures of smooth muscle cellsPLoS One201384e6317723646193
   PubMed Web of Science ®Google Scholar
• FallisACancer nanotechnology plan 2015J Chem Inf Model2013531689169923800267
   PubMedGoogle Scholar
• WangMThanouMTargeting nanoparticles to cancerPharmacol Res201062909920380880
   PubMed Web of Science ®Google Scholar
• ParkKLeeSKangEKimKChoiKKwonICNew generation of multifunctional nanoparticles for cancer imaging and therapyAdv Funct Mater20091915531566
   Web of Science ®Google Scholar
• MuQWangHZhangMNanoparticles for imaging and treatment of metastatic breast cancerExpert Opin Drug Deliv201714112313627401941
   PubMed Web of Science ®Google Scholar
• HuangYFanC-QDongHWangS-MYangX-CYangS-MCurrent applications and future prospects of nanomaterials in tumor therapyInt J Nanomed20171218151825
   PubMed Web of Science ®Google Scholar
• FengBXuZZhouFNear infrared light-actuated gold nanorods with cisplatin-polypeptide wrapping for targeted therapy of triple negative breast cancerNanoscale20157148541486426222373
   PubMed Web of Science ®Google Scholar
• ZhaoJBabiuchKLuHDagAGottschaldtMStenzelMHFructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapyChem Commun2014501592815931
   PubMed Web of Science ®Google Scholar
• EnglertCPröhlMCzaplewskaJAd-Fructose-decorated poly(ethylene imine) for human breast cancer cell targetingMacromol Biosci2017178
   PubMed Web of Science ®Google Scholar
• ZhouXQinXGongTZhangZ-RFuYd-Fructose modification enhanced internalization of mixed micelles in breast cancer cells via GLUT5 transportersMacromol Biosci2017177
   Web of Science ®Google Scholar
• LiYPeiYZhangXPEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in ratsJ Control Release20017120321111274752
   PubMed Web of Science ®Google Scholar
• TangSYinQZhangZCo-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancerBiomaterials2014356047605924797883
   PubMed Web of Science ®Google Scholar
• DinarvandRSepehriNManoochehriSRouhaniHAtyabiFPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agentsInt J Nanomedicine2011687789521720501
   PubMed Web of Science ®Google Scholar
• TaheriADinarvandRAhadiFKhorramizadehMRAtyabiFThe in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c miceInt J Pharm201243118318922531853
   PubMed Web of Science ®Google Scholar
• DuanXXiaoJYinQZhangZYuHMaoSLiYSmart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and DisulfiramACS Nano201375858586923734880
   PubMed Web of Science ®Google Scholar
• HeQZhangZGaoFLiYShiJIn vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylationSmall2011727128021213393
   PubMed Web of Science ®Google Scholar
• GaoYChenYJiXControlled Intracellular Release of Doxorubicin in Multidrug-Resistant Cancer Cells by Tuning the Shell-Pore Sizes of Mesoporous Silica NanoparticlesACS Nano201159788979822070571
   PubMed Web of Science ®Google Scholar
• AkbarzadehARezaei-SadabadyRDavaranSLiposome: classification, preparation, and applicationsNanoscale Res Lett2013810223432972
   PubMed Web of Science ®Google Scholar
• GhasemaliSNejati-KoshkiKTafsiriEInhibitory effects of β-cyclodextrin-helenalin complexes on H-TERT gene expression in the T47D breast cancer cell line - results of real time quantitative PCRAsian Pac J Cancer Prev201314116949695324377631
   PubMedGoogle Scholar
• DaiJNagaiTWangXZhangTMengMZhangQpH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine AInt J Pharm20042801–222924015265562
   PubMed Web of Science ®Google Scholar
• WangZYuYDaiWThe use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancerBiomaterials201233338451846022940213
   PubMed Web of Science ®Google Scholar
• ZhangYZhangHWangXWangJZhangXZhangQThe eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micellesBiomaterials201233267969122019123
   PubMed Web of Science ®Google Scholar
• FengQYuM-ZWangJ-CSynergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core–shell nanoparticlesBiomaterials201435185028503824680191
   PubMed Web of Science ®Google Scholar
• FaridbodFGanjaliMRDinarvandRNorouziPRiahiSSchiff’s Bases and Crown Ethers as Supramolecular Sensing Materials in the Construction of Potentiometric Membrane SensorsSensors (Basel)2008831645170327879786
   PubMed Web of Science ®Google Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
   PubMed Web of Science ®Google Scholar
• XuRZhangGMaiJAn injectable nanoparticle generator enhances delivery of cancer therapeuticsNat Biotechnol20163441441826974511
   PubMed Web of Science ®Google Scholar
• HrkachJVon HoffDAliMMPreclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological ProfileSci Transl Med20124128128ra39
   PubMed Web of Science ®Google Scholar
• OhnoSTakanashiMSudoKSystemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cellsMol Ther201321118519123032975
   PubMed Web of Science ®Google Scholar
• DanhierFLe BretonAPréatVRGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and DiagnosisMol Pharm20129112961297322967287
   PubMed Web of Science ®Google Scholar
• GeJLanMZhouBA graphene quantum dot photodynamic therapy agent with high singlet oxygen generationNat Commun20145
   Web of Science ®Google Scholar
• YuanHFalesAMVo-DinhTTAT Peptide-Functionalized Gold Nanostars: Enhanced Intracellular Delivery and Efficient NIR Photothermal Therapy Using Ultralow IrradianceJ Am Chem Soc201213428135811361
   Web of Science ®Google Scholar
• ChengLYangKLiYZengXShaoMLeeS-TLiuZMultifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapyBiomaterials20123372215222222169825
   PubMed Web of Science ®Google Scholar
• KingHWMichaelMZGleadleJMHypoxic enhancement of exosome release by breast cancer cellsBMC Cancer20121242122998595
   PubMed Web of Science ®Google Scholar
• AmoozgarZYeoYRecent advances in stealth coating of nanoparticle drug delivery systemsWiley Interdiscip Rev Nanomedicine Nanobiotechnology20124221923322231928
   PubMed Web of Science ®Google Scholar
• PecotCVRupaimooleRYangDTumour angiogenesis regulation by the miR-200 familyNat Commun20134242724018975
   PubMed Web of Science ®Google Scholar
• SheWLiNLuoKGuoCWangGGengYGuZDendronized heparin−doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapyBiomaterials20133492252226423298778
   PubMed Web of Science ®Google Scholar
• Miller-KleinhenzJMBozemanENYangLTargeted nanoparticles for image-guided treatment of triple-negative breast cancer: Clinical significance and technological advancesWiley Interdiscip Rev Nanomedicine Nanobiotechnology20157679781625966677
   PubMed Web of Science ®Google Scholar
• NúñezCCapeloJLIgrejasGAlfonsoABotanaLMLodeiroCAn overview of the effective combination therapies for the treatment of breast cancerBiomaterials201697345027162073
   PubMed Web of Science ®Google Scholar